Publisher Correction: A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells

Affiliations

• ¹ Sanofi R&D, North America, Cambridge, MA, USA.
• ² ModeX Therapeutics, Natick, MA, USA.
• ³ Sanofi R&D, Frankfurt, Frankfurt am Main, Germany.
• ⁴ Dragonfly Therapeutics, Waltham, MA, USA.
• ⁵ Sanofi R&D, Montpellier, Montpellier, France.
• ⁶ GSK, Waltham, MA, USA.
• ⁷ Sanofi R&D, North America, Cambridge, MA, USA. Lily.Pao@sanofi.com.
• ⁸ Jounce Therapeutics, Cambridge, MA, USA.
• ⁹ Sanofi R&D, North America, Cambridge, MA, USA. Zhi-yong.Yang@modextx.com.
• ¹⁰ ModeX Therapeutics, Natick, MA, USA. Zhi-yong.Yang@modextx.com.
• ¹¹ Sanofi R&D, North America, Cambridge, MA, USA. Gary.Nabel@modextx.com.
• ¹² ModeX Therapeutics, Natick, MA, USA. Gary.Nabel@modextx.com.